Compare Tempus AI (TEM) vs Tesla, Inc. (TSLA) Price & Performance

Tempus AI (TEM) trades at $48.41, down 7.74% in the last 24 hours, reflecting a bearish technical signal. The company reported revenue of $1.27 billion in 2025 but a net loss of $245.03 million, with negative profitability metrics. Recent news highlights growth in AI-driven diagnostics and data services, including FDA approvals and research collaborations. The stock is trading well below the analyst consensus price target of $68.50, with a majority of analysts maintaining a Buy rating.

The outlook for TEM is a mix of high growth potential in healthcare AI and significant financial risk due to persistent losses. Investment opportunity lies in its proprietary data platform and expanding market reach, but risks include execution challenges and cash burn. Wall Street sentiment remains positive on long-term prospects, but investors should weigh the volatility against the company's unproven path to profitability.

Tesla trades at $378.99, down 0.49% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows elevated valuation ratios (P/E 339.06, P/S 13.34) despite recent earnings beats in Q4 2025 and Q1 2026. Revenue declined to $94.83B in 2025, with net income margin compressing to 3.95%. Positive developments include regulatory approval for driver-assistance software in Europe and a potential cheaper EV model, though delivery misses and competitive pressures weigh on sentiment.

Tesla's outlook balances innovation in autonomy and energy against slowing auto growth and high valuations. The consensus price target of $409.26 suggests modest upside, but risks include execution on robotaxis, margin pressure, and macroeconomic headwinds. Institutional ownership shifts and mixed analyst ratings (38% Buy, 43% Hold) reflect cautious optimism, with the stock's trajectory hinging on AI and energy segments offsetting EV deceleration.